Carnegie Embryology presents: A Science in the Neighborhood public lecture with Dr. Alexandria Forbes, President and CEO of clinical-stage gene therapy company MeiraGTx.

MeiraGTx is focused on developing curative treatments for patients living with serious diseases. Their research and development efforts are concentrated on three areas with distinct medical needs: Ocular, neurodegenerative, and salivary gland diseases. People who suffer from these conditions currently have zero-to-limited treatment options; however, gene therapy has high potential to provide meaningful clinical benefits.

Dr. Alexandria Forbes has served as President and CEO of MeiraGtx since March 2015. Before joining MeiraGTx, Dr. Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, and spent 12 years as a healthcare investor at Sivik Global Healthcare and at Meadowvale Asset Management.

Prior to entering the hedge fund and biopharmaceutical industries, Dr. Forbes was a Human Frontiers/Howard Hughes postdoc at the Skirball Institute of Biomolecular Medicine and a research fellow in the Spradling Lab at Carnegie Embryology. She received her MA in Natural Sciences from Cambridge University and her PhD in Molecular Genetics from Oxford University.

Read the original here:
Science in the Neighborhood Public Lecture Dr. Alexandria Forbes - Carnegie Institution for Science